France Diabetes Care Devices Market Outlook to 2025 – Glucose Monitoring and Insulin Delivery

Pages: 121 Published: April 30, 2020 Report Code: GDMEMC0528DB

GlobalData’s “France Diabetes Care Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the France Diabetes Care Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Glucose Monitoring and Insulin Delivery.

The France Diabetes Care Devices Market report provides key information and data on:

• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.

• 2019 company share and distribution share data for Diabetes Care Devices Market.

• Global corporate-level profiles of key companies operating within the France Diabetes Care Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

France Diabetes Care Devices is segmented as follows:

• Glucose Monitoring and Insulin Delivery

Reasons to Buy

Key Reasons to Purchase – The France Diabetes Care Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key Players

Key companies covered in the “France Diabetes Care Devices Market Outlook to 2025” report:

• DexCom Inc

• Medtronic Plc

• Abbott Laboratories

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 5

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Diabetes Care Devices Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Diabetes Care Devices Market, France 10

3.1 Diabetes Care Devices Market, France, Revenue ($m), 2015-2025 10

3.2 Diabetes Care Devices Market, France, Revenue Mix ($m), 2019 12

3.3 Diabetes Care Devices Market, France, Category Contribution by Revenue ($m), 2019 13

3.4 Diabetes Care Devices Market, France, Revenue ($m), 2015-2025 14

3.5 Diabetes Care Devices Market, France, Volume (Units), 2015-2025 16

3.6 Diabetes Care Devices Market, France, Volume (Units), 2015-2025 18

3.7 Diabetes Care Devices Market, France, Company Share by Revenue ($m), 2019 20

4 Glucose Monitoring Market, France 22

4.1 Glucose Monitoring Market, France, Revenue ($m), 2015-2025 22

4.1.1 Blood Glucose Meters Market, France, Revenue ($m), by Segment, 2015-2025 24

4.2 Glucose Monitoring Market, France, Volume (Units), 2015-2025 26

4.2.1 Blood Glucose Meters Market, France, Volume (Units), by Segment, 2015-2025 28

4.3 Glucose Monitoring Market, France, Average Price ($) , 2015-2025 30

4.4 Glucose Monitoring Market, France, Distribution Share by Revenue ($m), 2019 31

4.5 Glucose Monitoring Market, France, Company Share by Revenue ($m), 2019 32

5 Insulin Delivery Market, France 33

5.1 Insulin Delivery Market, France, Revenue Mix ($m), 2019 33

5.2 Insulin Delivery Market, France, Segment Contribution (%), 2019 34

5.3 Insulin Delivery Market, France, Revenue ($m), 2015-2025 35

5.3.1 Insulin Pens Market, France, Revenue ($m), by Segment, 2015-2025 37

5.3.2 Insulin Pumps Market, France, Revenue ($m), by Segment, 2015-2025 39

5.4 Insulin Delivery Market, France, Volume (Units), 2015-2025 41

5.4.1 Insulin Pens Market, France, Volume (Units), by Segment, 2015-2025 43

5.4.2 Insulin Pumps Market, France, Volume (Units), by Segment, 2015-2025 45

5.5 Insulin Delivery Market, France, Average Price ($), 2015-2025 47

5.6 Insulin Delivery Market, France, Distribution Share by Revenue ($m), 2019 48

5.7 Insulin Delivery Market, France, Company Share by Revenue ($m), 2019 49

6 Overview of Key Companies in France, Diabetes Care Devices Market 51

6.1 DexCom Inc 51

6.1.1 Company Overview 51

6.2 Medtronic Plc 51

6.2.1 Company Overview 51

6.3 Abbott Laboratories 51

6.3.1 Company Overview 51

6.4 Novo Nordisk AS 52

6.4.1 Company Overview 52

6.5 Sanofi 52

6.5.1 Company Overview 52

6.6 Eli Lilly and Co 52

6.6.1 Company Overview 52

6.7 F. Hoffmann-La Roche Ltd 53

6.7.1 Company Overview 53

6.8 Ypsomed Holding AG 53

6.8.1 Company Overview 53

7 Diabetes Care Devices Market Pipeline Products 54

8 Financial Deals Landscape 55

8.1 Debt Offerings 55

8.1.1 Sanofi Prices Public Offering of

1.000% Notes Due 2025 for USD804.8 Million 55

8.1.2 Sanofi Prices Public Offering of

1.500% Notes Due 2030 for USD804.8 Million 56

8.2 Equity Offerings 57

8.2.1 Beurer Invests USD2.51 Million in PKvitality 57

8.3 Partnerships 58

8.3.1 Biocorp Production Enters into Agreement with Amalgam Rx (iSage Rx) 58

8.3.2 Sanofi and Abbott Enter into Partnership 59

8.3.3 LifeScan Enters into Distribution Agreement with Sanvita Medical 60

8.3.4 Diabeloop and ViCentra Enter into Distribution Agreement 61

8.4 Venture Financing 62

8.4.1 Diabeloop Raises USD34 Million in Series B Financing 62

9 Recent Developments 64

9.1 Corporate Communications 64

9.1.1 Mar 04, 2020: Sanofi's Board of Directors proposes the appointment of Rachel Duan and Lise Kingo as independent directors 64

9.1.2 Feb 25, 2020: Sanofi announces resignation of Director 65

9.1.3 Dec 04, 2019: Duke Health: New, non-hormonal target identified for advanced prostate cancer 65

9.1.4 Oct 15, 2019: Northwell Health extends partnership with comprehensive Allscripts Sunrise platform through 2027 66

9.1.5 Jul 29, 2019: Sanofi: Appointment of additional director and whole time director 67

9.1.6 Jul 26, 2019: Sanofi : Information on the departure conditions of Olivier Brandicourt, Chief Executive Officer 67

9.1.7 Jun 07, 2019: Paul Hudson to succeed Olivier Brandicourt as chief executive officer 68

9.1.8 Apr 09, 2019: Voluntis appoints Berkley Nelson as Chief Growth Officer 69

9.2 Financial Announcements 69

9.2.1 Feb 06, 2020: Sanofi delivers strong 2019 business EPS growth of

6.8% at CER 69

9.2.2 Jan 27, 2020: Theraclion demonstrates its leadership in thyroid and veins none invasive treatments 79

9.2.3 Oct 31, 2019: Sanofi Q3 well on track 80

9.2.4 Oct 17, 2019: The Bristol-Myers Squibb-Pfizer alliance and Fitbit collaborate to address gaps in Atrial Fibrillation Detection with the aim of accelerating diagnosis 83

9.2.5 Sep 19, 2019: Voluntis reports business review and financial results for first half of 2019 85

9.2.6 Sep 16, 2019: Theraclion: Half year results 2019 87

9.2.7 Jul 29, 2019: Sanofi delivered solid growth in Q2 2019 88

9.2.8 Jul 22, 2019: Growth in first half 2019 sales of Theraclion SA: + 12% 97

9.2.9 May 15, 2019: Atara Biotherapeutics announces presentations highlighting Mesothelin-Targeted CAR T clinical results at American Society of Clinical Oncology (ASCO) Annual Meeting 98

9.3 Legal And Regulatory 99

9.3.1 Oct 03, 2019: Lilly announces voluntary delisting from Euronext Paris 99

9.3.2 Sep 30, 2019: Adocia announces receipt of USD

14.3 million payment from Eli Lilly following arbitration conclusion and the decision by mutual consent with Eli Lilly to conclude the civil case 101

9.3.3 Aug 23, 2019: Adocia announces that the American Arbitration Association Tribunal Dismissed all Claims in Second Phase of Arbitration With Eli Lilly 101

9.4 Other Significant Developments 102

9.4.1 Jan 14, 2020: BIOCORP and SANOFI strengthen their partnership with Mallya Smart Sensors 102

9.4.2 Jun 19, 2019: Gamida Cell and Lonza establish commercial manufacturing agreement for omidubicel 102

9.4.3 Apr 26, 2019: Sanofi delivers strong Q1 2019 business EPS growth of

9.4% at CER 103

9.4.4 Apr 10, 2019: Sanofi provides unprecedented access to its insulins for one set monthly price 110

9.5 Research And Development 111

9.5.1 Sep 13, 2019: Aimmune stock trading halted; FDA Allergenic Products Advisory Committee (APAC) meeting to discuss PALFORZIA (AR101) for Peanut Allergy 111

9.6 Strategy And Business Planning 111

9.6.1 Oct 15, 2019: Sanofi opens digital manufacturing facility in the US 111

9.6.2 May 21, 2019: Verily forms strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to transform clinical research 112

10 Appendix 115

10.1 Research Methodology 116

10.1.1 Coverage 116

10.1.2 Secondary Research 116

10.1.3 Primary Research 117

10.1.4 Market Modeling and Forecasting 117

10.1.5 Company Share Analysis 119

10.1.6 Distribution Share Analysis 119

10.1.7 Benchmarking 120

10.2 GlobalData Consulting 120

10.3 Contact Us 121

10.4 Disclaimer 121

List of Tables

1.1 List of Tables

Table 1: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, 2015-2025 11

Table 2: Diabetes Care Devices Market, France, Category Contribution by Revenue ($m), 2019 13

Table 3: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Historic, 2015-2020 15

Table 4: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Forecast, 2021-2025 15

Table 5: Diabetes Care Devices Market, France, Volume (Units), 2015-2025 17

Table 6: Diabetes Care Devices Market, France, Volume (Units), Historic, 2015-2020 19

Table 7: Diabetes Care Devices Market, France, Volume (Units), Forecast, 2021-2025 19

Table 8: Diabetes Care Devices Market, France, Company Share by Revenue ($m), USD Constant, 2019 21

Table 9: Glucose Monitoring Market, France, Revenue ($m), USD Constant, 2015-2020 23

Table 10: Glucose Monitoring Market, France, Revenue ($m), USD Constant, 2021-2025 23

Table 11: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, 2015-2020 25

Table 12: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, 2021-2025 25

Table 13: Glucose Monitoring Market, France, Volume (Units), 2015-2020 27

Table 14: Glucose Monitoring Market, France, Volume (Units), 2021-2025 27

Table 15: Blood Glucose Meters Market, France, Volume (Units), 2015-2020 29

Table 16: Blood Glucose Meters Market, France, Volume (Units), 2021-2025 29

Table 17: Glucose Monitoring Market, France, Average Price ($), 2015-2020 30

Table 18: Glucose Monitoring Market, France, Average Price ($), 2021-2025 30

Table 19: Glucose Monitoring Market, France, Distribution Share by Revenue ($m), USD Constant, 2019 31

Table 20: Glucose Monitoring Market, France, Company Share by Revenue ($m), USD Constant, 2019 32

Table 21: Insulin Delivery Market, France, Segment Contribution (%), 2019 34

Table 22: Insulin Delivery Market, France, Revenue ($m), USD Constant, 2015-2020 36

Table 23: Insulin Delivery Market, France, Revenue ($m), USD Constant, 2021-2025 36

Table 24: Insulin Pens Market, France, Revenue ($m), USD Constant, 2015-2020 38

Table 25: Insulin Pens Market, France, Revenue ($m), USD Constant, 2021-2025 38

Table 26: Insulin Pumps Market, France, Revenue ($m), USD Constant, 2015-2020 40

Table 27: Insulin Pumps Market, France, Revenue ($m), USD Constant, 2021-2025 40

Table 28: Insulin Delivery Market, France, Volume (Units), 2015-2020 42

Table 29: Insulin Delivery Market, France, Volume (Units), 2021-2025 42

Table 30: Insulin Pens Market, France, Volume (Units), 2015-2020 44

Table 31: Insulin Pens Market, France, Volume (Units), 2021-2025 44

Table 32: Insulin Pumps Market, France, Volume (Units), 2015-2020 46

Table 33: Insulin Pumps Market, France, Volume (Units), 2021-2025 46

Table 34: Insulin Delivery Market, France, Average Price ($), 2015-2020 47

Table 35: Insulin Delivery Market, France, Average Price ($), 2021-2025 47

Table 36: Insulin Delivery Market, France, Distribution Share by Revenue ($m), USD Constant, 2019 48

Table 37: Insulin Delivery Market, France, Company Share by Revenue ($m), USD Constant, 2019 50

Table 38: Diabetes Care Devices Market Pipeline Products 54

Table 39: Sanofi Prices Public Offering of 1.000% Notes Due 2025 for USD804.8 Million 55

Table 40: Sanofi Prices Public Offering of 1.500% Notes Due 2030 for USD804.8 Million 56

Table 41: Beurer Invests USD2.51 Million in PKvitality 57

Table 42: Biocorp Production Enters into Agreement with Amalgam Rx (iSage Rx) 58

Table 43: Sanofi and Abbott Enter into Partnership 59

Table 44: LifeScan Enters into Distribution Agreement with Sanvita Medical 60

Table 45: Diabeloop and ViCentra Enter into Distribution Agreement 61

Table 46: Diabeloop Raises USD34 Million in Series B Financing 62

List of Figures

1.2 List of Figures

Figure 1: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, 2015-2025 10

Figure 2: Diabetes Care Devices Market, France, Revenue Mix ($m), 2019 12

Figure 3: Diabetes Care Devices Market, France, Category Contribution (%), 2019 13

Figure 4: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Historic, 2015-2025 14

Figure 5: Diabetes Care Devices Market, France, Volume (Units), 2015-2025 16

Figure 6: Diabetes Care Devices Market, France, Volume (Units), Historic, 2015-2025 18

Figure 7: Diabetes Care Devices Market, France, Company Share (%) 2019 20

Figure 8: Glucose Monitoring Market, France, Revenue ($m), USD Constant, 2015-2025 22

Figure 9: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, 2015-2025 24

Figure 10: Glucose Monitoring Market, France, Volume (Units), 2015-2025 26

Figure 11: Blood Glucose Meters Market, France, Volume (Units), 2015-2025 28

Figure 12: Glucose Monitoring Market, France, Company Share (%) 2019 32

Figure 13: Insulin Delivery Market, France, Revenue Mix ($m), 2019 33

Figure 14: Insulin Delivery Market, France, Segment Contribution (%), 2019 34

Figure 15: Insulin Delivery Market, France, Revenue ($m), USD Constant, 2015-2025 35

Figure 16: Insulin Pens Market, France, Revenue ($m), USD Constant, 2015-2025 37

Figure 17: Insulin Pumps Market, France, Revenue ($m), USD Constant, 2015-2025 39

Figure 18: Insulin Delivery Market, France, Volume (Units), 2015-2025 41

Figure 19: Insulin Pens Market, France, Volume (Units), 2015-2025 43

Figure 20: Insulin Pumps Market, France, Volume (Units), 2015-2025 45

Figure 21: Insulin Delivery Market, France, Company Share (%) 2019 49

Frequently Asked Questions

Enquire Before Buying
$5995

Can be used by individual purchaser only

$17985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.